|
Reaction Name | Pathway Name / Pathway No. | Kf | Kb | Kd | tau | Reagents |
1 | Stoch_Basal_ CaMKII_PSD | CaMKII_PSD
Pathway No. 292 | 1 (s^-1) | 1 (s^-1) | Keq = 1(uM) | 0.5sec | Substrate: basal_CaMKII_ PSD_control
Products: basal_CaMKII_ PSD
|
| This reaction comes into play when stochastic calculations are used. If we do not have a stochastic step here then the levels of basal_CaMKII_PSD are just a fixed number, which is probably not a good representation of stochasticity. Having a reaction for the basal activity ensures that the basal activity too exhibits some fluctuations. | 2 | CaMKII-diss-CaM | CaMKII_PSD
Pathway No. 292 | 5 (s^-1) | 0 (uM^-1 s^-1) | - | - | Substrate: CaMKII-CaM-PSD
Products: CaM-Ca4-PSD CaMKII-PSD
|
3 | CaMKII-bind-CaM- PSD | CaMKII_PSD
Pathway No. 292 | 49.9998 (uM^-1 s^-1) | 0 (s^-1) | - | - | Substrate: CaMKII-PSD CaM-Ca4-PSD
Products: CaMKII-CaM-PSD
|
4 | CaMKII-thr286-bi nd-CaM-PSD | CaMKII_PSD
Pathway No. 292 | 1000.02 (uM^-1 s^-1) | 0.1 (s^-1) | Kd(bf) = 0.0001(uM) | - | Substrate: CaMKII-thr286-PS D CaM-Ca4-PSD
Products: CaMKII-thr286-Ca M-PSD
|
| Same values as for the main compartment Can the main compartment pool of Ca/CaM be used? | 5 | back_2 | CaMKII_PSD
Pathway No. 292 | 0.3 (s^-1) | 0 (#^-1 s^-1) | Not applicable** | - | Substrate: CaMKII-thr305-PS D
Products: CaMK-thr305 NMDAR
|
| Same as for back_1 | 6 | back_1 | CaMKII_PSD
Pathway No. 292 | 0.3 (s^-1) | 0 (#^-1 s^-1) | Not applicable** | - | Substrate: CaMKII-PSD
Products: CaMKII NMDAR
|
| Rates set by the translocation experiments of Shen and Meyer, Science 1999. Note that this reaction also incorporates a translocation between compartments of different volumes. | 7 | transloc_1 | CaMKII_PSD
Pathway No. 292 | 0 (#^-1 s^-1) | 0 (s^-1) | Not applicable** | - | Substrate: CaMKII-CaM NMDAR
Products: CaMKII-CaM-PSD
|
| Rates to match curve in fig2 from Shen and Meyer, Science 284:162-166(1999), calculated for 6:1 alpha:beta CaMKII heterodimers Note that this reaction also incorporates a translocation between compartments of different volumes. | 8 | transloc_2 | CaMKII_PSD
Pathway No. 292 | 0 (#^-1 s^-1) | 0 (s^-1) | Not applicable** | - | Substrate: CaMKII-thr286*-C aM NMDAR
Products: CaMKII-thr286-Ca M-PSD
|
| Same as for transloc_1 | 9 | CaM-bind-AC1 | AC
Pathway No. 289 | 49.9997 (uM^-1 s^-1) | 1 (s^-1) | Kd(bf) = 0.02(uM) | - | Substrate: CaM-Ca4 AC1
Products: AC1-CaM
|
| Half-max at 20 nM CaM (Tang et al JBC 266:13 8595-8603 1991 kb/kf = 20 nM = 12000 #/cell so kf = kb/12000 = kb * 8.333e-5 | 10 | dephosph-AC2 | AC
Pathway No. 289 | 0.1 (s^-1) | 0 (s^-1) | - | - | Substrate: AC2*
Products: AC2
|
| Random rate. | 11 | dephosph-PDE | AC
Pathway No. 289 | 0.01 (s^-1) | 0 (s^-1) | - | - | Substrate: cAMP-PDE*
Products: cAMP-PDE
|
| The rates for this are poorly constrained. In adipocytes (probably a different PDE) the dephosphorylation is complete within 15 min, but there are no intermediate time points so it could be much faster. Identity of phosphatase etc is still unknown. | 12 | CaM_bind_PDE1 | AC
Pathway No. 289 | 719.982 (uM^-1 s^-1) | 5 (s^-1) | Kd(bf) = 0.0069(uM) | - | Substrate: PDE1 CaM-Ca4
Products: CaM.PDE1
|
| For olf epi PDE1, affinity is 7 nM. Assume same for brain. Reaction should be pretty fast. Assume kb = 5/sec. Then kf = 5 / (0.007 * 6e5) = 1.2e-3 | 13 | cAMP_diffusion | AC
Pathway No. 289 | 300 (s^-1) | 5.4 (s^-1) | Not applicable** | - | Substrate: cAMP
Products: cAMP_in_dend
|
| Represents diffusion, from a volume of 9e-20 to 5e-18. Assuming neck dimensions of 0.1 x 0.1 microns, this works out to a diffusion const of about 270 um^2/sec, which is pretty conservative. It is what cAMP does in frog cilia. | 14 | cAMP-bind-site-B 1 | PKA
Pathway No. 288 | 54 (uM^-1 s^-1) | 33 (s^-1) | Kd(bf) = 0.6111(uM) | - | Substrate: R2C2 cAMP
Products: R2C2-cAMP
|
| Hasler et al FASEB J 6:2734-2741 1992 say Kd =1e-7M for type II, 5.6e-8 M for type I. Take mean which comes to 2e-13 #/cell Smith et al PNAS USA 78:3 1591-1595 1981 have better data. First kf/kb=2.1e7/M = 3.5e-5 (#/cell). Ogreid and Doskeland Febs Lett 129:2 287-292 1981 have figs suggesting time course of complete assoc is < 1 min. | 15 | cAMP-bind-site-B 2 | PKA
Pathway No. 288 | 54 (uM^-1 s^-1) | 33 (s^-1) | Kd(bf) = 0.6111(uM) | - | Substrate: R2C2-cAMP cAMP
Products: R2C2-cAMP2
|
| For now let us set this to the same Km (1e-7M) as site B. This gives kf/kb = .7e-7M * 1e6 / (6e5^2) : 1/(6e5^2) = 2e-13:2.77e-12 Smith et al have better values. They say that this is cooperative, so the consts are now kf/kb =8.3e-4 | 16 | cAMP-bind-site-A 1 | PKA
Pathway No. 288 | 75.0006 (uM^-1 s^-1) | 110 (s^-1) | Kd(bf) = 1.4667(uM) | - | Substrate: R2C2-cAMP2 cAMP
Products: R2C2-cAMP3
|
17 | cAMP-bind-site-A 2 | PKA
Pathway No. 288 | 75.0006 (uM^-1 s^-1) | 32.5 (s^-1) | Kd(bf) = 0.4333(uM) | - | Substrate: cAMP R2C2-cAMP3
Products: R2C2-cAMP4
|
18 | Release-C1 | PKA
Pathway No. 288 | 60 (s^-1) | 17.9998 (uM^-1 s^-1) | Kd(cb) = 0.3(uM) | - | Substrate: R2C2-cAMP4
Products: PKA-active R2C-cAMP4
|
| This has to be fast, as the activation of PKA by cAMP is also fast. kf was 10 | 19 | Release-C2 | PKA
Pathway No. 288 | 60 (s^-1) | 17.9998 (uM^-1 s^-1) | Kd(cb) = 0.3(uM) | - | Substrate: R2C-cAMP4
Products: PKA-active R2-cAMP4
|
20 | inhib-PKA | PKA
Pathway No. 288 | 59.9994 (uM^-1 s^-1) | 1 (s^-1) | Kd(bf) = 0.0167(uM) | - | Substrate: PKA-active PKA-inhibitor
Products: inhibited-PKA
|
| This has to be set to zero for matching the expts in vitro. In vivo we need to consider the inhibition though. kf = 1e-5 kb = 1 |